APA (7th ed.) Citation

Barr, P. M., Miller, T. P., Friedberg, J. W., Peterson, D. R., Baran, A. M., Herr, M., . . . Briehl, M. M. (2014). Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma. Blood, 124(8), 1259. https://doi.org/10.1182/blood-2014-04-570044

Chicago Style (17th ed.) Citation

Barr, Paul M., et al. "Phase 2 Study of Imexon, a Prooxidant Molecule, in Relapsed and Refractory B-cell Non-Hodgkin Lymphoma." Blood 124, no. 8 (2014): 1259. https://doi.org/10.1182/blood-2014-04-570044.

MLA (9th ed.) Citation

Barr, Paul M., et al. "Phase 2 Study of Imexon, a Prooxidant Molecule, in Relapsed and Refractory B-cell Non-Hodgkin Lymphoma." Blood, vol. 124, no. 8, 2014, p. 1259, https://doi.org/10.1182/blood-2014-04-570044.